Researchers have identified a possible route through which exercise influences aging cartilage: tiny particles circulating in blood that carry molecular signals between cells. The study, published September 29 in Nature Aging, combines human exercise samples with laboratory and mouse experiments, offering a potential target for research on preserving mobility in later life.

The work connects exercise-responsive microRNA-29 with changes in cartilage-cell biology and the gene encoding α-Klotho. Its strongest treatment-related findings come from experimental models. It does not establish that administering these particles improves pain, walking ability or osteoarthritis progression in people.

Following signals from blood to cartilage

According to Mass General Brigham’s accompanying research release, older adults completed a structured aerobic exercise program, with blood collected before and after three months of training. Researchers examined extracellular vesicles—small particles released by cells—and tested how their contents affected cartilage cells and joint tissue.

The institution describes a research program spanning molecular analysis, cell culture, aging-associated osteoarthritis models in mice and human exercise interventions. That combination allowed the investigators to explore both what changed after exercise and whether selected signals could produce biological effects in experimental systems.

The paper reports increased microRNA-29 in vesicles following the exercise intervention. Computational analysis identified this molecule as a candidate regulator of cartilage aging. In cell experiments, exercise-associated vesicles relieved suppression of KL, the gene encoding α-Klotho, and improved measures of cartilage-cell condition.

Vesicles engineered to carry microRNA-29 reproduced anabolic, or tissue-building, effects involving KL. Administering exercise-associated vesicles into the joints of aged mice also improved cartilage health. Together, these experiments support a biological mechanism that warrants further testing.

Why mobility matters for healthspan

Osteoarthritis can restrict the everyday activities that allow people to remain independent. The World Health Organization describes it as a condition affecting the entire joint, with pain, stiffness and swelling making movement difficult. Reduced movement can contribute to loss of muscle strength and further limitations in physical activity.

In its July 2023 fact sheet, WHO estimated that 528 million people worldwide were living with osteoarthritis in 2019. The knee was the most frequently affected joint. These are historical estimates, but they illustrate the scale of the problem motivating research into joint preservation.

WHO also identifies exercise as part of osteoarthritis management because it can strengthen muscles and support mobility. Understanding the molecular response to exercise could help explain some of its effects, while opening questions about additional approaches for people whose pain or disability limits activity.

The gap between a mechanism and a treatment

The researchers’ institutional release presents vesicles and their molecular cargo as possible foundations for future therapies. That is a development prospect rather than an established clinical application. The human component described in the release supplied blood samples for mechanistic investigation; it did not demonstrate the effectiveness of a vesicle treatment in patients.

A key next question is whether the experimental changes translate into outcomes people can feel or use: less pain, better movement and sustained function. Cartilage-cell measurements and mouse tissue findings cannot answer that question by themselves. Any therapeutic approach would also need evidence about safety and durability.

For aging research, the immediate contribution is a testable explanation for communication between exercise-responsive blood components and joint tissue. Whether that explanation can yield a practical intervention remains unresolved.

AI-assisted reporting disclosure

AI assisted with source organization and drafting. Vitalspan Wire is accountable for the published text and maintains a revision record.

Medical note

This article provides general information, not diagnosis or treatment advice. Consult a qualified clinician before making medical decisions.